Advertisement
Screener

ARTELO BIOSCIENCES, INC. (ARTL) Repayments of Convertible Debt

1.4 / 5 stars · 10/35 Roast Me

ARTELO BIOSCIENCES, INC. Repayments of Convertible Debt

ARTELO BIOSCIENCES, INC. (ARTL) reported Repayments of Convertible Debt of $1.03 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.

Financial Statements › Cash Flow › Financing Activities

us-gaap:RepaymentsOfConvertibleDebt · last filed 2026-08-12

Period endRepayments of Convertible Debt 6 monthRepayments of Convertible Debt 12 month
2026-06-30$1.03M
10-Q · filed 2026-08-12
2025-12-31$24.00K
8-K · filed 2026-03-17
2025-06-30$0.00
10-Q · filed 2026-08-12
2024-12-31$0.00
8-K · filed 2026-03-17

Similar stocks

Stock NameCountryMarket CapPE Ratio
TherapeuticsMD, Inc. (TXMD)United States$0.024B-117.87
NextCure, Inc. (NXTC)United States$0.024B-0.15
Cocrystal Pharma, Inc. (COCP)United States$0.022B
AYTU BIOPHARMA, INC (AYTU)United States$0.025B-1.62
ATOSSA THERAPEUTICS, INC. (ATOS)United States$0.021B-0.52
Neuphoria Therapeutics Inc. (NEUP)United States$0.020B-1.77
Marker Therapeutics, Inc. (MRKR)United States$0.020B-2.86
Cellectar Biosciences, Inc. (CLRB)United States$0.020B-1.03
Shuttle Pharmaceuticals Holdings, Inc. (SHPH)United States$0.019B-0.31
Rocket One Inc. (RKTO)United States$0.019B